745041-80-9

Basic information

• Product Name: 2-tricosanoylamino-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-3,4-O-isopropylidene-D-ribo-1,3,4-nonanetriol
• Synonyms: 2-tricosanoylamino-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-3,4-O-isopropylidene-D-ribo-1,3,4-nonanetriol
• CAS NO: 745041-80-9
• Molecular Weight: 1090.58
• Mol File: 745041-80-9.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 2-tricosanoylamino-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-3,4-O-isopropylidene-D-ribo-1,3,4-nonanetriol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-tricosanoylamino-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-3,4-O-isopropylidene-D-ribo-1,3,4-nonanetriol(745041-80-9)
• EPA Substance Registry System: 2-tricosanoylamino-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-3,4-O-isopropylidene-D-ribo-1,3,4-nonanetriol(745041-80-9)

Safety Data

• Hazardous Substances Data: 745041-80-9(Hazardous Substances Data)

Upstream product

• 745041-64-9 (2S,3S,4R)-2-azido-3,4-O-isopropylidene-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-1,3,4-nonanetriol 
• 745041-56-9 (2S,3S,4R)-2-azido-3,4-O-isopropylidene-1,3,4-nonanetriol 
• 570414-15-2 (2R,3R,4R)-2-O-methanesulfonyl-1,2,3,4-nonanetetrol 
• 570414-16-3 (2S,3S,4R)-2-azido-nonane-1,3,4-triol 
• 942623-41-8 C₁₇H₂₆O₆S 
• 956028-66-3 C₁₆H₂₄O₄ 
• 918867-23-9 4,5-anhydro-1,3-O-benzylidene-D-arabitol 
• 2433-96-7 tricosanoic acid 
• 745041-72-9 (2S,3S,4R)-2-amino-3,4-O-isopropylidene-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-1,3,4-nonanetriol 

Downstream Products

• 745042-03-9 2-tricosanoylamino-1-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-D-ribo-1,3,4-nonanetriol 

Relevant articles and documents

Synthesis and biological evaluation of truncated α-galactosylceramide derivatives focusing on cytokine induction profile

A series of truncated analogs of α-galactosylceramide with altered ceramide moiety was prepared, and evaluated for Th2-biased response in the context of IL-4/IFN-γ ratio. Phytosphingosine-modified analogs including cyclic, aromatic and ethereal compounds

GLYCOLIPID DERIVATIVES, PROCESS FOR PRODUCTION OF THE SAME, INTERMEDIATES FOR SYNTHESIS THEREOF, AND PROCESS FOR PRODUCTION OF THE INTERMEDIATES

Novel glycolipid derivatives, where the substituent of the sphingosine base part is a short carbon chain alkyl group, substituted or unsubstituted cycloalkyl group, substituted or unsubstituted aryl group or substituted or unsubstituted aralkyl group and